DCX and prostate neoplasm: In this study, based on the Hi‐Myc prostate adenocarcinoma mouse model, the genetic depletion of DCX+ cells, as well as the surgical or chemical ablation of sympathetic nerves, inhibited prostate tumor growth and metastases.